E-LIB Suche - Ergebnisse für: Qi, Junyuan

1

Phase I study of the Syk inhibitor sovleplenib in relapsed ..:

Song, Yuqin ; Cao, Junning ; Zhang, Qingyuan...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

2

Patients with acquired pure red cell aplasia respond to PI3..:

Wang, Zhenzhen ; Jiang, Bo ; Song, Lin...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

3

Safety and Pharmacokinetics of Quizartinib Combination Ther..:

Qi, Junyuan ; Choi, Ilseung ; Ota, Shuichi...
Clinical Pharmacology in Drug Development. 13 (2024) 5 - p. 560-571 , 2024

Link: https://doi.org/10.1002/..

4

P635: AN UPDATE OF SAFETY AND EFFICACY RESULTS FROM PHASE 1..:

Xu, Wei ; Feng, Ru ; Wang, LI...
HemaSphere. 7 (2023) S3 - p. e324590c , 2023

Link: https://doi.org/10.1097/..

5

B‐cell maturation antigen chimeric antigen receptor‐T thera..:

Wang, Yunhong ; Zhang, Ke ; Suo, Xiaohui...
ESC Heart Failure. 11 (2023) 1 - p. 574-580 , 2023

Link: https://doi.org/10.1002/..

6

Pharmacokinetics of single- and multiple-dose flumatinib in..:

Jiang, Bo ; Qi, Junyuan ; Sun, Mingyuan...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

7

Efficacy and safety of GLS-010 (zimberelimab) in patients w..:

Lin, Ningjing ; Zhang, Mingzhi ; Bai, Hai...
European Journal of Cancer. 164 (2022) - p. 117-126 , 2022

Link: https://doi.org/10.1016/..

8

A two‐part, single‐arm, multicentre, phase I study of zanub..:

Song, Yuqin ; Sun, Mingyuan ; Qi, Junyuan...
British Journal of Haematology. 198 (2022) 1 - p. 62-72 , 2022

Link: https://doi.org/10.1111/..

9

Safety and efficacy of daratumumab in Chinese patients with..:

Jing, Hongmei ; Yang, Li ; Qi, Junyuan...
Annals of Hematology. 101 (2022) 12 - p. 2679-2690 , 2022

Link: https://doi.org/10.1007/..

10

Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in p..:

Jiang, Bo ; Qi, Junyuan ; Song, Yuqin...
Journal of Hematology & Oncology. 14 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

11

Pharmacokinetics, Safety, and Pharmacodynamics of Romiplost..:

Qi, Junyuan ; Zheng, Li ; Hu, Bei...
Clinical Pharmacology in Drug Development. 11 (2021) 3 - p. 379-387 , 2021

Link: https://doi.org/10.1002/..

12

Pharmacokinetics and safety of IBI301 versus rituximab in p..:

Jiang, Bo ; Ke, Xiaoyan ; Zhang, Qingyuan...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

13

Superior efficacy of rituximab-based chemoimmunotherapy as ..:

Li, Zengjun ; Li, Fei ; Yi, Shuhua...
BMC Cancer. 15 (2015) 1 - p. , 2015

Link: https://doi.org/10.1186/..

14

Cytogenetic and clinical marks for defining high-risk myelo..:

An, Gang ; Acharya, Chirag ; Deng, Shuhui...
Experimental Hematology. 43 (2015) 3 - p. 168-176.e2 , 2015

Link: https://doi.org/10.1016/..

15

Features of Extramedullary Disease of Multiple Myeloma: Hig..:

Deng, Shuhui ; Xu, Yan ; An, Gang...
Clinical Lymphoma Myeloma and Leukemia. 15 (2015) 5 - p. 286-291 , 2015

Link: https://doi.org/10.1016/..